Viking Therapeutics, Inc. (VKTX)
37.21
-0.32
(-0.85%)
USD |
NASDAQ |
Dec 11, 16:00
37.37
+0.16
(+0.43%)
After-Hours: 20:00
Viking Therapeutics Market Cap: 4.206B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 903.41B |
| Pfizer Inc. | 146.69B |
| Amgen, Inc. | 170.90B |
| Altimmune, Inc. | 558.23M |
| Terns Pharmaceuticals, Inc. | 4.242B |
Market Cap Related Metrics
| PEG Ratio | -0.1393 |
| Price to Book Value | 5.899 |
| Price | 37.21 |
| Earnings Yield | -5.69% |
| PEGY Ratio | -0.1393 |